Effects of Interleukin (IL)-17A Inhibition on Idiopathic Subglottic Stenosis

NCT05309616 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Subglottic Stenosis

Interventions

DRUG: Taltz

Sponsor

Yale University

Collaborators

[object Object]